Archives
-
Genotyping Kit for target alleles: Workflow Guide
2026-09-09
Accelerate PCR-based genotyping across insects, tissues, fishes, and cultured cells with a single-tube DNA preparation workflow. This guide connects rapid allele testing with experimental models such as intestinal E-cadherin research while emphasizing controls, assay optimization, and interpretation limits.
-
PF-573228 FAK Inhibitor Workflow
2026-09-09
Use PF-573228 to connect focal adhesion signaling with matrix stiffness, cancer-cell motility, and endothelial behavior. This practical guide combines dose-aware treatment, phosphorylation readouts, mechanotransduction controls, and troubleshooting for reproducible FAK research.
-
L-Threonine for Metabolic and ALP Workflows
2026-09-08
Use L-Threonine to build controlled nutrient-availability experiments, then pair those perturbations with a metal-free alkaline phosphatase readout. This workflow separates amino acid effects on cell metabolism from assay interference while supporting cell culture optimization, metabolic profiling, and nutritional intervention studies.
-
Trolox Beyond the Antioxidant Assay
2026-09-08
Trolox is more than an antioxidant benchmark. This thought-leadership guide explains how 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid can help translational researchers separate broad redox protection from lipid-specific injury, improve assay design, and interpret ferroptosis-related findings across oxidative injury research, neurodegeneration studies, and cancer biology research.
-
Cytochalasin B: From Actin Mechanism to Translation
2026-09-07
Cytochalasin B, also known as NSC 107658, is more than an actin-disrupting reagent: it is a reversible perturbation strategy for connecting cytoskeletal mechanism with translational assay design. This article outlines how to validate target engagement, interpret cytotoxicity data, and position the compound responsibly in drug discovery and preclinical research.
-
AM251 for Pain-Circuit Dissection
2026-09-07
AM251 is a CB1 receptor antagonist for separating receptor-level signaling from circuit-wide pain and affective phenotypes. This article translates recent CBD pain research into practical assay logic, controls, and interpretation strategies for neuroscience research.
-
Trichostatin A (TSA): Practical Lab Protocol
2026-09-05
Trichostatin A (TSA), SKU A8183, is a reversible HDAC inhibitor for controlled studies of histone acetylation, epigenetic regulation in cancer, differentiation, and cell proliferation. It is appropriate for research workflows with matched vehicle controls and assay-specific optimization, but dossier concentrations and animal-model parameters should not be treated as universal dosing instructions.
-
CX-4945: A Causal Map of CK2 Biology
2026-09-04
CX-4945 (Silmitasertib) is a selective CK2 inhibitor for connecting kinase target engagement with cancer phenotypes and host-factor biology. This article presents an evidence-driven assay framework that extends beyond viability testing to pathway, cell-cycle, apoptosis, and viral-replication readouts.
-
2',7'-Dichlorofluorescein Diacetate ROS Workflow
2026-09-04
Use the 2',7'-Dichlorofluorescein diacetate probe to quantify intracellular redox changes across microscopy, flow cytometry, and plate-based experiments. This practical guide connects assay design and troubleshooting with ROS-responsive nanocarrier research in pancreatic cancer.
-
Malate: A Flux-First Guide to Mitochondrial Assays
2026-09-03
Malate is more than a tricarboxylic acid cycle intermediate: it is a controllable probe of mitochondrial redox, metabolic flux, and tumor–immune communication. This guide translates recent cholangiocarcinoma findings into rigorous malate assay strategies and interpretation controls.
-
FH1: Practical iHep Maturation Workflow
2026-09-03
FH1 (Catalog No. B3700) supports a controlled approach to iPS cell differentiation to hepatocytes by improving albumin output, CYP3A4-associated maturity, and hepatocyte-like morphology. This guide translates those effects into a reproducible screening workflow, assay strategy, and troubleshooting plan for liver modeling and translational research.
-
(R)-MG132: A Control for Metabolic Mechanisms
2026-09-02
(R)-MG132 is a functionally inactive MG-132 enantiomer for separating proteasome-dependent effects from nonspecific cellular responses. This guide shows how to apply that stereochemical control to mechanistic studies of HNRNPU lactylation, PHGDH regulation, and serine metabolism.
-
Icariside II and mTOR Signaling in Renal Fibrosis
2026-09-02
This study combines network pharmacology, molecular dynamics, and cell-based validation to identify mTOR as a plausible direct target of icariside II in renal fibrosis. Its findings connect stable predicted ligand binding with reduced TGF-β1-induced collagen I and α-SMA expression, while also illustrating the need for biochemical and in vivo validation.
-
Lipid Peroxidation (MDA) Assay Kit in Ferroptosis
2026-09-01
Learn how the Lipid Peroxidation (MDA) Assay Kit can convert ferroptosis biology into an interpretable biochemical endpoint. This guide connects MDA chemistry with SLC7A11–GSH–GPX4 signaling, experimental controls, and assay-selection decisions in cancer research.
-
RG108: DNA Methyltransferase Inhibitor Guide
2026-09-01
RG108 is a small-molecule DNA methyltransferase inhibitor for studying DNA methylation and epigenetic gene regulation modulation. Product information reports biochemical DNMT inhibition, a 600 nM IC50 in the M.SssI assay, and a cell-culture application in HL-60 leukemia cells.